Zoetis Inc (ZTS)
167.07
-0.16
(-0.10%)
USD |
NYSE |
May 03, 16:00
167.02
-0.06
(-0.03%)
After-Hours: 20:00
Zoetis Free Cash Flow: 1.75B for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | 1.75B |
| December 31, 2023 | 1.621B |
| September 30, 2023 | 1.492B |
| June 30, 2023 | 1.285B |
| March 31, 2023 | 1.458B |
| December 31, 2022 | 1.326B |
| September 30, 2022 | 1.267B |
| June 30, 2022 | 1.429B |
| March 31, 2022 | 1.607B |
| December 31, 2021 | 1.736B |
| September 30, 2021 | 1.791B |
| June 30, 2021 | 1.702B |
| March 31, 2021 | 1.682B |
| December 31, 2020 | 1.673B |
| September 30, 2020 | 1.523B |
| June 30, 2020 | 1.456B |
| March 31, 2020 | 1.323B |
| December 31, 2019 | 1.335B |
| September 30, 2019 | 1.365B |
| June 30, 2019 | 1.463B |
| March 31, 2019 | 1.442B |
| December 31, 2018 | 1.452B |
| September 30, 2018 | 1.531B |
| June 30, 2018 | 1.446B |
| March 31, 2018 | 1.381B |
| Date | Value |
|---|---|
| December 31, 2017 | 1.122B |
| September 30, 2017 | 823.00M |
| June 30, 2017 | 614.00M |
| March 31, 2017 | 568.00M |
| December 31, 2016 | 497.00M |
| September 30, 2016 | 468.00M |
| June 30, 2016 | 438.00M |
| March 31, 2016 | 431.00M |
| December 31, 2015 | 440.00M |
| September 30, 2015 | 579.00M |
| June 30, 2015 | 488.00M |
| March 31, 2015 | 514.00M |
| December 31, 2014 | 431.00M |
| September 30, 2014 | 344.00M |
| June 30, 2014 | 342.00M |
| March 31, 2014 | 170.00M |
| December 31, 2013 | 497.00M |
| September 30, 2013 | 513.00M |
| June 30, 2013 | 502.00M |
| March 31, 2013 | 622.00M |
| December 31, 2012 | 328.00M |
| September 30, 2012 | 123.00M |
| June 30, 2012 | 232.00M |
| March 31, 2012 | 298.00M |
| December 31, 2011 | 362.00M |
Free Cash Flow Range, Past 5 Years
1.267B
Minimum
Sep 2022
1.791B
Maximum
Sep 2021
1.514B
Average
1.478B
Median
Free Cash Flow Benchmarks
| Biogen Inc | 1.284B |
| Pfizer Inc | 4.793B |
| Eli Lilly and Co | -3.896B |
| Bristol-Myers Squibb Co | 12.51B |
| Amgen Inc | 7.098B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 595.00M |
| Cash from Investing (Quarterly) | -131.00M |
| Cash from Financing (Quarterly) | -524.00M |
| Free Cash Flow Per Share (Quarterly) | 0.9917 |
| Free Cash Flow to Equity (Quarterly) | 436.00M |
| Free Cash Flow to Firm (Quarterly) | 475.85M |
| Free Cash Flow Yield | 2.27% |